Bright Peak Therapeutics
PrivateLast Round
Series C
Jun 11, 2024
Total Funding Raised
$232M
Company Overview
Bright Peak Therapeutics is a biotechnology company specializing in the development of immuno-cytokines aimed at treating cancer and autoimmune diseases through targeted cytokine therapeutics that enhance treatment efficacy and patient quality of life.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bright Peak Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Bright Peak Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 11, 2024 | ||||
| Series B | Jun 10, 2021 | ||||
| Series A | Jul 28, 2020 |
Bright Peak Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series C, Series B |
| Northleaf Capital Partners | Series C |
| KB Investment | Series C |
| Fidelity Management & Research Company | Series B, Series C |
| Versant Ventures | Series B, Series C, Series A |
| Venrock | Series C |
| Johnson & Johnson Innovation - JJDC, Inc. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2025
John Schmid appointed to the Board of Directors.
- Jan 6, 2025
Will present at the 43rd Annual J.P. Morgan Healthcare Conference.
Bright Peak Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bright Peak Therapeutics's valuation, stock price, and market status.
